Ixempra kit and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Ixempra kit (ixabepilone), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Carboplatin, and have Breast cancer.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Ixempra kit. It is created by eHealthMe based on reports of 984 people who have side effects when taking Ixempra kit from the FDA, and is updated regularly.

What is Ixempra kit?

Ixempra kit has active ingredients of ixabepilone. eHealthMe is studying from 991 Ixempra kit users. Check the latest studies of Ixempra kit.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,279 drugs and 1,654 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

On Jul, 12, 2026

984 people reported to have side effects when taking Ixempra kit.
Among them, 37 people (3.76%) have Dyspnea exacerbated.

Could Ixempra kit cause Dyspnea exacerbated?

Among these 37 people:

How long have people been on Ixempra kit when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Ixempra kit? *

female: 89.19 %
male: 10.81 %

What is the age of people who have Dyspnea exacerbated when taking Ixempra kit? *

What are other drugs people take besides Ixempra kit? *

Carboplatin: 9 people, 24.32%
Benadryl: 6 people, 16.22%
Decadron: 5 people, 13.51%
Gemzar: 4 people, 10.81%
Zofran: 4 people, 10.81%
Aloxi: 4 people, 10.81%
Medrol: 3 people, 8.11%
Levocetirizine Dihydrochloride: 3 people, 8.11%
Nystatin: 3 people, 8.11%
Hydergine: 3 people, 8.11%

What are other side effects people have besides Dyspnea exacerbated? *

Fatigue (feeling of tiredness): 10 people, 27.03%
Rashes (redness): 8 people, 21.62%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 6 people, 16.22%
Pleural Effusion (water on the lungs): 5 people, 13.51%
Neuropathy Peripheral (surface nerve damage): 5 people, 13.51%
Swallowing Difficulty: 5 people, 13.51%
Anaemia (lack of blood): 5 people, 13.51%
Weight Decreased: 4 people, 10.81%
Diarrhea: 4 people, 10.81%
Thrombocytopenia (decrease of platelets in blood): 4 people, 10.81%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 12 people, 32.43%
Breast Cancer: 12 people, 32.43%
Endometrial Cancer: 4 people, 10.81%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 4 people, 10.81%
Stomatitis (inflammation of mucous membrane of mouth): 3 people, 8.11%
Respiratory Tract Infection: 3 people, 8.11%
Rashes (redness): 3 people, 8.11%
Mucosal Inflammation (infection of mucous membrane): 3 people, 8.11%
Disease Progression: 3 people, 8.11%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Ixempra kit and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ixempra kit:

Ixempra kit (991 reports)

Browse all side effects of Ixempra kit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,280 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,654 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ixabepilone (the active ingredients of Ixempra kit) and Ixempra kit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.